"Ozempic Babies": GLP-1s, Fertility, and When to Stop Before Pregnancy

"Ozempic babies" are unplanned pregnancies in women taking GLP-1 medicines. Two things drive them: losing weight can restart ovulation, especially with PCOS, and tirzepatide and Foundayo can make birth-control pills less reliable for weeks after each dose change. Semaglutide's label says to stop at least two months before trying to conceive.

Are "Ozempic babies" real?

The phrase started on social media, and there is no registry that counts them. But the biology behind it is well documented. A 2026 review of GLP-1 medicines in women of reproductive age concluded that they "may improve ovulatory function and menstrual regularity, particularly in women with obesity or polycystic ovary syndrome, potentially increasing the likelihood of conception," and flagged unintended pregnancy as a real concern¹.

So the surprise is understandable. Many women who start a GLP-1 have been told, or have assumed, that their weight or PCOS makes pregnancy unlikely. The medicine can change that within months, sometimes before anyone has talked about contraception.

Why do GLP-1s make pregnancy more likely?

There are two separate effects, and they can stack.

1. Ovulation comes back. Excess weight and insulin resistance can suppress ovulation, and PCOS is the most common reason. As weight and insulin levels fall, cycles often become more regular. In a 2026 meta-analysis of seven randomized trials in 330 women with PCOS, liraglutide, an older daily GLP-1, significantly increased menstrual frequency and lowered androgen levels compared with control treatments². More regular periods usually mean more ovulation. If you have PCOS, our PCOS guide explains the metabolic side, and our guide to GLP-1s and your cycle covers what period changes to expect.

2. The pill may be absorbed less well. GLP-1 medicines slow how fast the stomach empties. For tirzepatide (Zepbound, Mounjaro) and the new pill Foundayo, the labels say this can reduce the effectiveness of birth-control pills, especially right after starting and after each dose increase³⁴⁵. Semaglutide was studied directly with a combined pill and did not reduce its absorption⁶, and the Wegovy label carries no pill warning⁷. The full contraception picture, including which methods are unaffected, is in our GLP-1 and birth control guide.

The 2023 international PCOS guideline, which lists semaglutide and liraglutide as options for weight management in PCOS, adds a practice point for clinicians: ensure effective contraception "when pregnancy is possible for women who take GLP-1 receptor agonists, as pregnancy safety data are lacking"⁸.

Do GLP-1s affect fertility if you don't have PCOS?

Nobody knows yet. A 2025 review of the question found that "no human studies to examine the effect of GLP-1 RAs on fertility in women without PCOS have been published"¹⁶. Animal studies point in different directions depending on the species, the drug and the dose: some showed lower reproductive hormone levels, others showed protective effects on the uterus¹⁶. None of that translates cleanly to a woman on a weekly injection.

What can be said is narrower. If excess weight was suppressing your cycles, losing it is likely to help them, whatever caused the weight. If your cycles were already regular, there is no good evidence that a GLP-1 changes your fertility in either direction. Either way, the safe assumption on these medicines is that you can conceive, and the plan should start from there.

Why are the labels so cautious?

The warnings come mostly from animal research and from the fact that weight loss is not a goal in pregnancy. The Wegovy label explains that "based on animal reproduction studies, there may be potential risks to the fetus," that human data "are insufficient to establish a drug-associated risk," and that "weight loss offers no benefit to a pregnant patient and may cause fetal harm"⁷. In plain terms: the medicines have not been shown to cause harm in human pregnancy, but they have not been shown to be safe either, and they do nothing useful once you are pregnant. Stopping is the low-risk default.

Which GLP-1s affect the pill, and how long should you stop before pregnancy?

Here is what each US label says, read on DailyMed in October 2026.

The Foundayo label's wording in full: "Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method or add a barrier method of contraception for 30 days after initiation with FOUNDAYO and for 30 days after each dose escalation"⁵. It also asks women who could become pregnant to use effective contraception throughout treatment⁵. Foundayo has several dose steps, so each increase restarts the 30-day window.

Compounded semaglutide and tirzepatide have no FDA label of their own. The same molecules behave the same way in the body, so most prescribers apply the brand-name rules.

How long should you wait after stopping a GLP-1 before trying to conceive?

For semaglutide the answer is on the label: at least two months, "because of the long half-life of semaglutide"⁷. Two months is roughly the time it takes for the drug to clear.

For tirzepatide and Foundayo the labels set no fixed washout. They say weight loss "offers no benefit to a pregnant patient and may cause fetal harm" and to stop the medicine once pregnancy is recognized³⁵. Because tirzepatide's half-life is about five to six days, it takes roughly a month to clear; Foundayo clears in about a week and a half. Many clinicians choose a buffer of one to two months for planned pregnancies anyway. That is a judgment call to make with your OB-GYN, not a label rule.

If you are planning IVF or another fertility treatment, the timing works differently because the cycle is scheduled. Our guide to GLP-1s before IVF covers how a reproductive endocrinologist usually sets the washout.

Will the weight come back while you wait?

Often some of it does. Appetite returns as the drug clears. Building eating and activity habits during the last months on the medicine, and talking with your clinician about a plan for the gap, can make the transition gentler. Weight loss during pregnancy is not recommended, so the goal during the gap is stability, not further loss.

What if you get pregnant while taking a GLP-1?

First: stop the medicine and call your OB-GYN or prescriber. Do not panic. The human data so far are reassuring, though not conclusive.

The honest reading: the studies do not show a large increase in birth defects after early exposure, but they mostly involve women with type 2 diabetes on older GLP-1s, the numbers are small for any single drug, and tirzepatide and Foundayo have far less data. Animal studies did raise concerns, which is why the labels are cautious⁷. A 2026 review written for clinicians caring for women with type 2 diabetes concluded that the human evidence "does not support a recommendation of terminating pregnancy" after an inadvertent exposure¹⁵.

Pregnancy exposure registries

The drug makers run registries that collect outcomes from women exposed during pregnancy. Joining helps the next woman get a clearer answer. The numbers below are printed on each label³⁵⁷:

• Wegovy: Novo Nordisk, 1-877-390-2760
• Zepbound: 1-844-524-0039
• Foundayo: Eli Lilly, 1-800-545-5979

How do you plan a pregnancy around a GLP-1?

A practical sequence, to adapt with your clinicians:

1. Decide your timeline early. If pregnancy is likely in the next year, say so at your first visit. It can change which medicine makes sense.
2. Settle contraception before the first dose. If you use the pill and start tirzepatide or Foundayo, add condoms or switch to a non-oral method during each window in the table above. An IUD, implant, shot, patch or ring avoids the issue.
3. Expect cycles to change. If periods that were irregular become regular, treat that as a sign you may be ovulating.
4. Stop on time. At least two months ahead for semaglutide; agree on a buffer for tirzepatide or Foundayo.
5. Start prenatal care basics. Folic acid and a preconception visit apply to everyone, and are worth starting before you stop the medicine.
6. Plan for after the birth. Whether and when to restart depends on breastfeeding. The Wegovy and Ozempic tablets are not recommended while breastfeeding; the injections are handled differently. See what the evidence shows on GLP-1s and breastfeeding.

Which programs are set up for this conversation?

A prescriber who asks about pregnancy plans and contraception before writing the first prescription is worth more than a lower monthly price. Our ranking of GLP-1 programs for women and our board for women with PCOS show what each program includes. We earn a commission when you start treatment through some links on this site, at no extra cost to you. CoreAge Rx is a featured partner, and providers we work with may appear first. If you are comparing, our reviews of CoreAge Rx, Eden and Sprout Health describe how each handles intake.

Educational content, not medical advice. Talk to a licensed clinician, ideally your OB-GYN, before starting or stopping any treatment around pregnancy.